Geron to Announce First Quarter 2022 Financial Results on May 9, 2022
May 02 2022 - 4:30PM
Business Wire
Geron Corporation (Nasdaq: GERN) today announced that it will
release its first quarter 2022 financial results after the market
closes on Monday, May 9, 2022 via press release, which will be
available on the Company’s website at www.geron.com/investors.
Geron will host a conference call to discuss the financial results
as well as recent highlights at 4:30 p.m. ET the same day.
A live webcast of the conference call and related presentation
will be available on the Company’s website at
www.geron.com/investors/events. An archive of the webcast will be
available on the Company’s website for 30 days.
Participants may access the webcast by registering online using
the following link, https://conferencingportals.com/event/SmvlMvWL.
Participants that are unable to register online can access the
conference call via telephone by dialing domestically +1 (888)
330-2434 or internationally +1 (240) 789-2725. The conference ID is
67335.
About Geron
Geron is a late-stage clinical biopharmaceutical company focused
on the development and potential commercialization of a
first-in-class telomerase inhibitor, imetelstat, in hematologic
malignancies. The Company currently is conducting two Phase 3
clinical trials: IMerge in lower risk myelodysplastic syndromes and
IMpactMF in refractory myelofibrosis.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220502005041/en/
Aron Feingold Investor and Media Relations investor@geron.com
media@geron.com
Geron (NASDAQ:GERN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Geron (NASDAQ:GERN)
Historical Stock Chart
From Sep 2023 to Sep 2024